Dale A. Sander - Nov 16, 2025 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
CFO and Chief Corp. Deve. Off.
Signature
/s/ Dale A. Sander
Stock symbol
HUMA
Transactions as of
Nov 16, 2025
Transactions value $
$0
Form type
4
Date filed
11/17/2025, 05:52 PM
Previous filing
Apr 14, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sander Dale A. CFO and Chief Corp. Deve. Off. 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM /s/ Dale A. Sander 2025-11-17 0001878193

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Award $0 +311K +15555% $0.00 313K Nov 16, 2025 Direct F1
holding HUMA Common Stock 40.6K Nov 16, 2025 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units (RSUs), which represent a contingent right to receive one share of Common Stock for each RSU. The first 50% of the RSUs will vest on May 15, 2026, after which the remaining 50% of the RSUs will vest on May 15, 2027.